Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study
about
P2Y2 receptor agonists for the treatment of dry eye disease: a reviewTherapeutic Strategies to Treat Dry Eye in an Aging PopulationDiquafosol ophthalmic solution 3 %: a review of its use in dry eye.Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes.Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED).Anti-inflammatory effects of hinokitiol on human corneal epithelial cells: an in vitro studyTopical diquafosol for patients with obstructive meibomian gland dysfunction.Emerging drugs for the treatment of dry eye disease.An update on dry eye disease molecular treatment: advances in drug pipelines.Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.How To Form a Phosphate Anhydride Linkage in Nucleotide Derivatives.Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye.[Novel current and future therapy options for treatment of dry eye disease].Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery.Expression of the P2Y₂ receptor on the rat ocular surface during a 1-year rearing period.Immediate Effect of 3% Diquafosol Ophthalmic Solution on Tear MUC5AC Concentration and Corneal Wetting Ability in Normal and Experimental Keratoconjunctivitis Sicca Rat Models.A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore.Current and emerging therapy of dry eye disease. Part A: pharmacological modalities
P2860
Q24608339-4377AB46-DDB3-4319-83F4-3ED976CC9077Q26822610-DAC3985F-9E39-4EE6-BE69-9AA1CB7FC8FBQ35629673-93B68CA4-17AA-497B-A512-FB616435CA57Q35647454-3621496E-0666-480B-98CF-ADA998B3EF55Q35805082-1DC57C04-8CCB-47BC-8FA9-CC8058C5BD1AQ35863016-48A9DD7A-2278-4893-91A0-4FF74493DE0BQ36876737-8263FE84-AA7D-4539-B183-CE555475B7A2Q38102006-212774A5-ABB1-41DC-9396-775D3B39E7C2Q38207723-9788857B-3DA5-4D87-A45E-729322B87220Q38209468-1767F2C3-B18A-4679-BE30-B6DF4F15C580Q38595373-67EE369D-78D7-48B3-BED0-48589D9DED50Q47777396-C2EDF6C3-983C-4D17-B1B7-C9A2125F3E0EQ50039889-ABCC6B91-D63C-4A0A-B658-249A1C8EE3A5Q50880549-8C2A4270-B52C-47F2-889B-55AA7CBA2266Q51116390-04787C60-BAE1-46C8-BD41-3C59A8FA8399Q51357621-DA973678-50FE-444A-BAFE-916B8EAE6368Q53625697-1C82B1CB-0345-480E-BE68-EC4CB318AFEBQ57378488-4D0E8845-D7D3-4504-BD44-1E33CB061249
P2860
Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Clinical evaluation of the add ...... randomized, multicenter study
@ast
Clinical evaluation of the add ...... randomized, multicenter study
@en
type
label
Clinical evaluation of the add ...... randomized, multicenter study
@ast
Clinical evaluation of the add ...... randomized, multicenter study
@en
prefLabel
Clinical evaluation of the add ...... randomized, multicenter study
@ast
Clinical evaluation of the add ...... randomized, multicenter study
@en
P2093
P2860
P356
P1433
P1476
Clinical evaluation of the add ...... randomized, multicenter study
@en
P2093
A Igarashi
M Nakanishi
P2860
P2888
P304
P356
10.1038/EYE.2012.166
P577
2012-08-10T00:00:00Z